Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Cytological-energy analysis of pleural effusions with predominance of neutrophils

I. Matuchova, P. Kelbich, J. Kubalik, E. Hanuljakova, I. Stanek, V. Maly, O. Karpjuk, J. Krejsek

. 2020 ; 14 (-) : 1753466620935772. [pub] -

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21020843

BACKGROUND: The predominance of neutrophils in pleural effusions of patients with different serious impairments of the pleural cavity organs is often found. The aim of this study was to identify the type of injury using the cytological-energy analysis of pleural effusions. METHODS: We analysed 635 samples of pleural effusions with predominance of neutrophils. We compared the values of the coefficient of energy balance (KEB), lactate dehydrogenase (LDH) and aspartate aminotransferase (AST) catalytic activities in the following subgroups of patients: with transudative effusions, purulent pneumonia, chest empyema and after chest surgery with and without purulent complications. Statistical analysis was performed using the ANOVA Kruskal-Wallis test (p < 0.05 was considered as significant). RESULTS: We found the lowest KEB values in pleural effusions of patients with chest empyema and their gradual increases in patients with purulent pneumonia and with transudative effusions. We observed the highest LDH and AST enzymes activity in patients with chest empyema and their gradual decrease in patients with purulent pneumonia and with transudative effusions. LDH and AST enzymes activity was significantly higher in pleural effusions of patients after chest surgery with purulent complications compared with non-purulent cases. CONCLUSION: The most intensive inflammation and the most extensive tissue destruction in the pleural cavity were found in patients with chest empyema. Significantly better parameters were observed in patients with purulent pneumonia. The absence of serious inflammation and the absence of tissue destruction were typical for patients with transudative effusions. Finally, our results confirmed an anticipated higher tissue destruction in patients after chest surgery. Significantly worse injury was found in surgical patients with purulent complications compared with non-purulent ones. The reviews of this paper are available via the supplemental material section.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21020843
003      
CZ-PrNML
005      
20210830102456.0
007      
ta
008      
210728s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1177/1753466620935772 $2 doi
035    __
$a (PubMed)32600177
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Matuchova, Inka $u Biomedical Centre, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic $u Faculty of Medicine and University Hospital in Hradec Kralove, Department of Clinical Immunology and Allergology, Charles University in Prague, Hradec Kralove, Czech Republic $u Laboratory for Cerebrospinal Fluid, Neuroimmunology, Pathology and Special Diagnostics Topelex, Prague, Czech Republic
245    10
$a Cytological-energy analysis of pleural effusions with predominance of neutrophils / $c I. Matuchova, P. Kelbich, J. Kubalik, E. Hanuljakova, I. Stanek, V. Maly, O. Karpjuk, J. Krejsek
520    9_
$a BACKGROUND: The predominance of neutrophils in pleural effusions of patients with different serious impairments of the pleural cavity organs is often found. The aim of this study was to identify the type of injury using the cytological-energy analysis of pleural effusions. METHODS: We analysed 635 samples of pleural effusions with predominance of neutrophils. We compared the values of the coefficient of energy balance (KEB), lactate dehydrogenase (LDH) and aspartate aminotransferase (AST) catalytic activities in the following subgroups of patients: with transudative effusions, purulent pneumonia, chest empyema and after chest surgery with and without purulent complications. Statistical analysis was performed using the ANOVA Kruskal-Wallis test (p < 0.05 was considered as significant). RESULTS: We found the lowest KEB values in pleural effusions of patients with chest empyema and their gradual increases in patients with purulent pneumonia and with transudative effusions. We observed the highest LDH and AST enzymes activity in patients with chest empyema and their gradual decrease in patients with purulent pneumonia and with transudative effusions. LDH and AST enzymes activity was significantly higher in pleural effusions of patients after chest surgery with purulent complications compared with non-purulent cases. CONCLUSION: The most intensive inflammation and the most extensive tissue destruction in the pleural cavity were found in patients with chest empyema. Significantly better parameters were observed in patients with purulent pneumonia. The absence of serious inflammation and the absence of tissue destruction were typical for patients with transudative effusions. Finally, our results confirmed an anticipated higher tissue destruction in patients after chest surgery. Significantly worse injury was found in surgical patients with purulent complications compared with non-purulent ones. The reviews of this paper are available via the supplemental material section.
650    _2
$a aspartátaminotransferasy $x analýza $7 D001219
650    _2
$a biologické markery $x analýza $7 D015415
650    _2
$a empyém pleurální $x diagnóza $x imunologie $x metabolismus $7 D016724
650    12
$a energetický metabolismus $7 D004734
650    _2
$a lidé $7 D006801
650    _2
$a L-laktátdehydrogenasa $x analýza $7 D007770
650    _2
$a neutrofily $x imunologie $x metabolismus $7 D009504
650    _2
$a pleurální výpotek $x diagnóza $x imunologie $x metabolismus $7 D010996
650    _2
$a pneumonie $x diagnóza $x imunologie $x metabolismus $7 D011014
650    _2
$a pooperační komplikace $x diagnóza $x imunologie $x metabolismus $7 D011183
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a hrudní chirurgické výkony $x škodlivé účinky $7 D019616
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kelbich, Petr $u Biomedical Centre, Masaryk Hospital in Usti nad Labem, Socialni pece 3316/12A, 401 13, Usti nad Labem, Czech Republic $u Faculty of Medicine and University Hospital in Hradec Kralove, Department of Clinical Immunology and Allergology, Charles University in Prague, Hradec Kralove, Czech Republic $u Laboratory for Cerebrospinal Fluid, Neuroimmunology, Pathology and Special Diagnostics Topelex, Prague, Czech Republic
700    1_
$a Kubalik, Jan $u Faculty of Medicine and University Hospital in Hradec Kralove, Department of Clinical Immunology and Allergology, Charles University in Prague, Hradec Kralove, Czech Republic $u Department of Thoracic Surgery, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic
700    1_
$a Hanuljakova, Eva $u Biomedical Centre, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic $u Laboratory for Cerebrospinal Fluid, Neuroimmunology, Pathology and Special Diagnostics Topelex, Prague, Czech Republic
700    1_
$a Stanek, Ivan $u Department of Thoracic Surgery, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic
700    1_
$a Maly, Vilem $u Department of Thoracic Surgery, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic
700    1_
$a Karpjuk, Ondrej $u Department of Thoracic Surgery, Masaryk Hospital in Usti nad Labem, Usti nad Labem, Czech Republic
700    1_
$a Krejsek, Jan $u Faculty of Medicine and University Hospital in Hradec Kralove, Department of Clinical Immunology and Allergology, Charles University in Prague, Hradec Kralove, Czech Republic
773    0_
$w MED00198806 $t Therapeutic advances in respiratory disease $x 1753-4666 $g Roč. 14, č. - (2020), s. 1753466620935772
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32600177 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830102457 $b ABA008
999    __
$a ok $b bmc $g 1691433 $s 1141289
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 14 $c - $d 1753466620935772 $e - $i 1753-4666 $m Therapeutic advances in respiratory disease $n Ther Adv Respir Dis $x MED00198806
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

Možnosti archivace